摘要
目的研究淋巴细胞免疫治疗复发性流产患者的临床效果。方法 100例复发性流产患者,按照患者意愿所选择的治疗方式将其分为免疫治疗组和安胎治疗组,免疫治疗组(57例)注射淋巴细胞免疫治疗,安胎治疗组(43例)采用注射黄体酮治疗,对比两组的妊娠结局,治疗有效率和不良反应。结果免疫治疗组治疗成功率为82.56%,明显高于安胎治疗组的20.93%,差异具有统计学意义(P<0.05);安胎治疗组不良反应发生率为2%,免疫治疗组不良反应发生率为4%,差异无统计学意义(P>0.05)。结论淋巴细胞免疫治疗复发性流产的有效率高,不良反应较低,是一种安全有效的治疗方式。
Objective To research the clinical effect of lymphocyte immunotherapy for recurrent spontaneous abortion patients. Methods A total of 100 recurrent spontaneous abortion patients were divided by their willing choice of treatment methods into immunotherapy group and tocolysis therapy group. The immunotherapy group （57 cases） received lymphocyte injection immunotherapy, and the tocolysis therapy group （43 cases） received progesterone injection. Pregnancy outcome, curative effective rate, and adverse reactions were compared between the two groups. Results The immunotherapy group had the treatment success rate as 82.56%, which was obviously higher than 20.93% of the tocolysis therapy group, and their difference had statistical significance （P〈0.05）. Incidence of adverse reactions in the tocolysis therapy group was 2%, and that in the immunotherapy group was 4%. Their difference had no statistical significance （P〉0.05）. Conclusion Lymphocyte immunotherapy has high effective rate and few adverse reactions in treating recurrent spontaneous abortion, and it is a safe and effective treatment method.
出处
《中国实用医药》
2015年第16期45-46,共2页
China Practical Medicine
关键词
复发性流产
淋巴细胞免疫治疗
安胎
Recurrent spontaneous abortion
Lymphocyte immunotherapy
Tocolysis
